Articles citing this paper
Research progress on hydroxyl protection of iridoid glycosides
Yuanfang Kong A * , Bin Yang A , Jingyu Zhang A and Chunhong Dong B C D *A College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.
B Henan Polysaccharide Research Center, Zhengzhou, Henan 450046, China.
C Henan Key Laboratory of Chinese Medicine for Polysaccharides and Drugs Research, Zhengzhou, Henan 450046, China.
D Academy of Chinese Medical Science, Henan University of Chinese Medicine, Zhengzhou, Henan 450046, China.
Yuanfang Kong received her master’s degree from Lanzhou University. In 2018, she graduated from Nankai University with a doctorate degree in organic chemistry. She now teaches at Henan University of Chinese Medicine and her research direction is drug design, synthesis and development and application. In recent years, she has contributed towards more than 20 research papers that have been published in academic journals, such as Organic Letters, Advanced Synthesis & Catalysis and European Journal of Organic Chemistry. She has received approval for two invention patents. |
Bin Yang is from Handan in Hebei, China. She studied medicinal chemistry at Henan University of Chinese Medicine, completing her undergraduate degree in 2019. She is pursuing her master’s degree at Henan Key Laboratory of Chinese Medicine for Polysaccharides and Drugs in Henan University of Chinese Medicine. Her research focuses on the structural modification and biological activity evaluation of iridoid glycosides. |
Jingyu Zhang, PhD, professor of Henan University of Chinese Medicine. His research direction is drug design, synthesis and development and application. Zhang Jingyu has presided over the China Postdoctoral Science Fund, Henan Province Science and Technology Research Project, Zhengzhou City Science and Technology Research Project, University Basic Research Business Fee Project and the Henan University of Traditional Chinese Medicine Innovation Talents Program. In recent years, he has contributed towards 30 research papers published in academic journals, such as Journal of Advanced Research, Analytica Chimica Acta, Tetrahedron Letters and European Journal of Medicinal Chemistry. He has received approval for three invention patents. |
Chunhong Dong, PhD, professor of Henan University of Chinese Medicine. Her research direction is drug design, synthesis and development and application. Chunhong Dong has published more than 50 academic papers and presided over six key scientific and technological projects of the National Natural Science Foundation of China and Henan Province. She has received approval for five invention patents. |
Australian Journal of Chemistry 75(4) 249-264 https://doi.org/10.1071/CH21260
Submitted: 5 October 2021 Accepted: 31 January 2022 Published: 13 April 2022